Custom-silicon deals can’t fix the real bottleneck: OSAT assembly-and-test capacity turns into the price lever

Marvell and Google’s custom-silicon collaboration was formalized with a securities-filed warrant structure: Google receives the right to buy up to 58,970,907 shares of Marvell at $206.58 per share (a maximum value of $12.18B / “$12.2 billion” if fully exercised), under a commercial agreement dated July 29, 2026. The technology scope is explicitly described as programs that attach to the TPU ecosystem (including inference and supporting data-movement/storage/network components).

That matters for OSAT because custom ASIC programs generally increase the number of qualified packaged devices that must be assembled, tested, and shipped to hyperscaler/ODM system lines. If advanced packaging steps and final test throughput aren’t scaled at the same pace, capacity utilization and changeover scheduling become the immediate pricing mechanism—often before any front-end wafer constraint shows up in financials.

Marvell’s disclosed scope focuses on TPU-adjacent processors and supporting data-path components. For OSAT, the direct linkage is not the TPU itself—it’s the packaged integrated circuits created from those custom programs and then validated in final test to meet system reliability targets.

If hyperscalers accelerate custom silicon ramps, the near-term order book tends to pull in parallel across packaging formats (e.g., flip-chip and advanced substrates) and across multiple test depths (functional, parametric, and reliability screening). That is where OSAT capacity becomes the swing factor: utilization rises, changeover frequency increases, and “premium capability” pricing can broaden—unless OSAT has already expanded capacity or carries enough underutilized lines.

The key takeaway isn’t that these margins are “high” or “low” today. It’s that OSAT operators carry operating leverage into the utilization rate: if custom-silicon ramp volumes push more units into packaging/test without immediate capacity add-ons, margins can be supported via pricing and better absorption—even if long-run capex eventually normalizes throughput.

Custom-silicon funding changes the shape of demand across cycles: hyperscalers move from merchant silicon to “their” silicon, but they still need qualified packaging/test output for every ramp increment. That shifts where constraints show up first.

The back-end often has less “elasticity” than investors assume because advanced packaging and final test capacity require physical equipment, validated processes, and test program readiness. That makes OSAT capacity utilization a potential first-order driver of near-to-intermediate pricing and output—exactly the kind of variable design/front-end focused models miss.

This article verifies the Marvell–Google custom-chip deal terms and TPU-attachment scope. However, it does not have a disclosed, primary-source mapping from that deal to specific OSAT outsource contracts, line allocations, or test format shares. Where that linkage is not disclosed in open primary materials, the analysis treats OSAT capacity as a probabilistic transmission mechanism—not as a named direct customer relationship.